Pregled bibliografske jedinice broj: 1059537
Serum eosinophil cationic protein in wheezing infants as a predictor of asthma development
Serum eosinophil cationic protein in wheezing infants as a predictor of asthma development // Allergy : european journal of allergy and clinical immunology, 55 (2000), Suppl 63; 113-113 (međunarodna recenzija, kratko priopcenje, znanstveni)
CROSBI ID: 1059537 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum eosinophil cationic protein in wheezing
infants as a predictor of asthma development
Autori
Ivković-Jureković, I ; Lokar-Kolbas, R ; Linarić, I
Izvornik
Allergy : european journal of allergy and clinical immunology (0105-4538) 55
(2000), Suppl 63;
113-113
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni
Ključne riječi
serum eosinophil cationic protein ; infants ; wheezing ; asthma
Sažetak
Wheezing infants have higher median serum ECP levels than children with nonwheezy respiratory tract infection or healthy subjects. In addition, wheezing infants with elevated serum ECP concentrations are more likely to have asthma within 1 year than patients with ECP levels within normal range. Eosinophil activation measured by serum ECP is present in infants with their first episode of wheezing illness, especially in those infants in whom asthma subsequently develops within 1 year. These data may indicate a predictive value of serum ECP measurements in children with wheezing to identify patients with increased risk for asthma development.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dječje bolesti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE